MEDIA RELEASE
8 May 2019 Parties use science to set themselves apart ….
The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.
Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]
by Alan Trounson
Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The Science Show.
A few weeks ago, 18 scientists from seven countries took me back forty years to a time when I was involved with the first IVF birth in Australia. Why? The scientists, writing in the journal […]
April 01, 2019
After 10 years in remission, Derek Ruff’s cancer returned, this […]
Tom Long’s battle with Multiple Myeloma
Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia. The story is heartbreaking, Tom is hanging on to hope. Hope that a CAR-T cell treatment that he has to […]
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.
This is not a distant vision. It is happening right here, right now. A research team, […]
Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.
Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019
Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.
 |
 |
New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factorieshttps://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […] ‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)Sydney Morning Herald (By Esther Han) 19 December 2018 — 12:00am A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine. Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […] |